0001183740-20-000255.txt : 20201125
0001183740-20-000255.hdr.sgml : 20201125
20201125170419
ACCESSION NUMBER: 0001183740-20-000255
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201125
DATE AS OF CHANGE: 20201125
EFFECTIVENESS DATE: 20201125
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novamind Ventures Inc.
CENTRAL INDEX KEY: 0001833397
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-381578
FILM NUMBER: 201351622
BUSINESS ADDRESS:
STREET 1: 10 WANLESS AVE, SUITE 201
CITY: TORONTO
STATE: A6
ZIP: M4N 1V6
BUSINESS PHONE: 6479539512
MAIL ADDRESS:
STREET 1: 10 WANLESS AVE, SUITE 201
CITY: TORONTO
STATE: A6
ZIP: M4N 1V6
D
1
primary_doc.xml
X0708
D
LIVE
0001833397
Novamind Ventures Inc.
10 WANLESS AVE, SUITE 201
TORONTO
A6
ONTARIO, CANADA
M4N 1V6
6479539512
ONTARIO, CANADA
The Psychedelic Pharma Company Inc.
None
Corporation
true
2019
Yaron
Conforti
10 Wanless Ave., Suite 201
Toronto
A6
ONTARIO, CANADA
M4N 1V6
Executive Officer
Director
Yisroel
Weinreb
10 Wanless Ave., Suite 201
Toronto
A6
ONTARIO, CANADA
M4N 1V6
Executive Officer
Director
Jesse
Kaplan
10 Wanless Ave., Suite 201
Toronto
A6
ONTARIO, CANADA
M4N 1V6
Director
Reid
Robison
10 Wanless Ave., Suite 201
Toronto
A6
ONTARIO, CANADA
M4N 1V6
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-11-10
false
true
true
true
true
C$1.00 Subscription Receipts, each Subscription Receipt is exercisable
into 4 common shares without any additional consideration upon satisfaction of certain escrow release conditions.
true
The Issuer issued the Subscription Receipts pursuant to a private placement in connection with a series of transactions, through which the business of the Issuer and Hinterland Metals Inc. will be combined, pursuant to a business combination agreement.
0
2153247
2153247
0
Total Offering Amount represents aggregate purchase price of 2,802,978 subscription receipts issued at C$1.00 on November 10, 2020. Exchange rate of US$1:C$1.3017.
false
13
0
0
0
false
Novamind Ventures Inc.
/s/ Yaron Conforti
Yaron Conforti
CEO
2020-11-25